General Information of the Compound
| Compound ID |
CP0433444
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1R,2R,3S,4R,5S)-4-[6-(ethylamino)-2-hex-1-ynylpurin-9-yl]bicyclo[3.1.0]hexane-2,3-diol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H25N5O2
|
||||||||||||||||||
| Molecular Weight |
355.442
|
||||||||||||||||||
| Canonical SMILES |
CCCCC#Cc1nc(NCC)c2ncn([C@@H]3[C@H]4C[C@H]4[C@@H](O)[C@H]3O)c2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H25N5O2/c1-3-5-6-7-8-13-22-18(20-4-2)14-19(23-13)24(10-21-14)15-11-9-12(11)16(25)17(15)26/h10-12,15-17,25-26H,3-6,9H2,1-2H3,(H,20,22,23)/t11-,12+,15+,16+,17-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
IKMHKZHQEKVSOG-GHVWTTSJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01279, Adenosine receptor A3
Protein ID: PT01827, Adenosine receptor A3